Quarterly report pursuant to Section 13 or 15(d)

Consolidated Interim Consolidated Statements of Operations and Comprehensive loss

v3.10.0.1
Consolidated Interim Consolidated Statements of Operations and Comprehensive loss - USD ($)
3 Months Ended 9 Months Ended
Aug. 31, 2018
Aug. 31, 2017
Aug. 31, 2018
Aug. 31, 2017
SALES $ 53,257 $ 70,353 $ 220,115 $ 209,958
COST OF SALES (29,302) (46,705) (148,515) (121,989)
GROSS PROFIT 23,955 23,648 71,600 87,969
EXPENSES:        
Depreciation 5,379 17,474 12,138 42,596
Amortization of patents 1,833 0 1,833 0
Foreign currency translation (gain) (5,898) 80,021 (17,498) 73,210
Selling, general and administration 385,556 433,759 1,091,424 1,544,953
TOTAL OPERATING EXPENSES 386,870 531,254 1,087,897 1,660,759
LOSS FROM OPERATIONS (362,915) (507,606) (1,016,297) (1,572,790)
Accretion (29,991) (94,134) (88,102) (249,405)
Change in fair value of derivative liabilities 307,201 122,967 245,852 718,667
Other expense- Interest (32,946) (82,928) (100,125) (279,729)
LOSS BEFORE INCOME TAXES (118,651) (561,701) (958,672) (1,383,257)
Income taxes 0 0 0 0
NET LOSS (118,651) (561,701) (958,672) (1,383,257)
Foreign exchange translation adjustment for the period (4,922) 2,062 (7,175) 23,858
COMPREHENSIVE LOSS $ (123,573) $ (559,639) $ (965,847) $ (1,359,399)
Loss per share - basic and diluted $ (0.001) $ (0.010) $ (0.010) $ (0.024)
Weighted average number of common shares outstanding 94,357,643 56,732,099 93,559,755 56,115,696